TECH - Wall Street Estimates - Bio-Techne Corporation

Healthcare - Biotechnology - NASDAQ - US

$ 75.83

-0.355 %

$ 12 B

Market Cap

79.82

P/E

Price Target Average

8.58%

Revenue Forecast Estimate

22.40%

EBIT Estimate

40.49%

Net Income Estimate

-0.00%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Bio-Techne Corporation

Wall Street analysts predict an average 1-year price target for TECH of $82.3 , with forecasts ranging from a low of $80 to a high of $84 .

TECH Lowest Price Target Wall Street Target

80 USD 5.50%

TECH Average Price Target Wall Street Target

82.3 USD 8.58%

TECH Highest Price Target Wall Street Target

84 USD 10.77%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free